Retinal dystrophy and immune factors

Interrogate the perturbations of the immune system in a cohort of young patients with a confirmed CRB1 mutation (NGS). Using cell purification systems, flow cytometry, metabolomics, proteomics and sequencing technologies, we will aim to map clinical and molecular endotypes of this severe condition.

Contact
Lude Moekotte